Grade: Research grade

Factory Location: Hangzhou

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe, Australasia,Asia,Middle East,Africa

Monthly Production Capacity: hundreds of grams

Packaging Information: 500mg,1g, 10g,50g 100g per package with icebag

Delivery Lead Time: In stock or 2-3weeks

Sample Provided: yes

Payment Terms: T/T

Ac2-26 TFA is the active N-terminal peptide of Annexin A1 (AnxA1). The sequence contains 25 amino acids and the N-terminal is blocked by an acetyl group. In vivo, it can reduce acute lung injury induced by ischemia-reperfusion, while also reducing the expression of AnxA1 protein, and inhibiting the activation of NF-κB and MAPK pathways in damaged lung tissue.